- Opportunities for tuberculosis elimination in the Canadian Arctic: cost-effectiveness of community-wide screening in a remote Arctic community. Zwerling A, Veerasingam E, Snyder E, Schertzer A, Travers K, Pim C, Pease C, Finn S, McElroy L, Allen J, Patterson M, Alvarez GG. Lancet Reg Health Am. 2024 Oct 30;40:100916.
- Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design. Alvarez GG, Sullivan K, Pease C, Van Dyk D, Mallick R, Taljaard M, Grimshaw JM, Amaratunga K, Allen C, Brethour K, Mulpuru S, Pakhale S, Aaron SD, Cameron DW, Alsdurf H, Hui C, Zwerling AA. Int J Infect Dis. 2022 Apr;117:222-229.
- Molecular epidemiology of Mycobacterium tuberculosis to describe the transmission dynamics among Inuit residing in Iqaluit Nunavut using whole genome sequencing, Alvarez GG, Zwerling AA, Duncan C, Pease C, Van Dyk D, Behr MA, Lee RS, Mulpuru S, Pakhale S, Cameron DW, Aaron SD, Patterson M, Allen J, Sullivan K, Jolly A, Sharma MK, Jamieson FB. Clinical Infectious Diseases. April 2020
- The implementation of rifapentine and isoniazid (3HP) for the treatment of latent TB infection in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study, Alvarez GG, Van Dyk D, Mallick R, Lesperance S, Demaio P, Finn S, Edmunds-Potvin S, Patterson M, Pease C, Amaratunga K, Hui C, Cameron DW, Mulpuru S, Aaron SD, Momoli F, Zwerling A. International Journal of Circumpolar Health. April 2020
- Social determinants of health among residential areas with a high tuberculosis incidence in a remote Inuit community, Kilabuk E, Momoli F, Mallick R, Van Dyk D, Pease C, Zwerling A, Edmunds-Potvin S, Alvarez GG. Journal of Epidemiology & Community Health. Senior author, student first author. January 2019.
- The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Alvarez GG, Dyk DDV, Desjardins M, Yasseen AS 3rd, Aaron SD, Cameron DW, Obed N, Baikie M, Pakhale S, Denklnger CM, Sohn H, Pal M. Chest. 2015 Sep;148(3):767-773.
- The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community. Alvarez GG, Van Dyk DD, Davies N, Aaron SD, Cameron DW, Desjardins M, Mallick R, Obed N, Baikie M.PLoS One. 2014 Nov 11;9(11):e111986.
- Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut. Alvarez GG, VanDyk DD, Aaron SD, Cameron DW, Davies N, Stephen N, Mallick R, Momoli F, Moreau K, Obed N, Baikie M, Osborne G. PLoS One. 2014 Jul 17;9(7):e100975.
All Other Publications
Opportunities for tuberculosis elimination in the Canadian Arctic: cost-effectiveness of community-wide screening in a remote Arctic community. Zwerling A, Veerasingam E, Snyder E, Schertzer A, Travers K, Pim C, Pease C, Finn S, McElroy L, Allen J, Patterson M, Alvarez GG. Lancet Reg Health Am. 2024 Oct 30;40:100916.
Lung disease burden assessment by oscillometry in a systematically disadvantaged urban population experiencing homelessness or at-risk for homelessness in Ottawa, Canada from a prospective observational study. Pakhale S, Visentin C, Tariq S, Kaur T, Florence K, Bignell T, Jama S, Huynh N, Boyd R, Haddad J, Alvarez GG. BMC Pulm Med. 2022 Jun 16;22(1):235.
Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design. Alvarez GG, Sullivan K, Pease C, Van Dyk D, Mallick R, Taljaard M, Grimshaw JM, Amaratunga K, Allen C, Brethour K, Mulpuru S, Pakhale S, Aaron SD, Cameron DW, Alsdurf H, Hui C, Zwerling AA. Int J Infect Dis. 2022 Apr;117:222-229.
Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country. Sullivan K, Pease C, Zwerling A, Mallick R, Van Dyk D, Mulpuru S, Allen C, Alsdurf H, Alvarez GG. BMC Public Health. 2021 May 21;21(1):964.
Latent tuberculosis infection cascade of care among adults in a low incidence country: a seven-year retrospective study, Sullivan K, Pease C, Zwerling A, Mallick R, Van Dyk D, Mulpuru S, Allen C, Alsdurf H, Alvarez GG. BMC Public Health. April 2021.
A case of relapsed Mycobacterium chelonae pulmonary infection presenting with severe weight loss and treated with a combination of antibiotic therapy and percutaneous feeding. Pease C, Alvarez GG. J Clin Tuberc Other Mycobact Dis. 2020 Dec 26;22:100209.
Molecular epidemiology of Mycobacterium tuberculosis to describe the transmission dynamics among Inuit residing in Iqaluit Nunavut using whole genome sequencing, Alvarez GG, Zwerling AA, Duncan C, Pease C, Van Dyk D, Behr MA, Lee RS, Mulpuru S, Pakhale S, Cameron DW, Aaron SD, Patterson M, Allen J, Sullivan K, Jolly A, Sharma MK, Jamieson FB. Clinical Infectious Diseases. April 2020
The implementation of rifapentine and isoniazid (3HP) for the treatment of latent TB infection in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study, Alvarez GG, Van Dyk D, Mallick R, Lesperance S, Demaio P, Finn S, Edmunds-Potvin S, Patterson M, Pease C, Amaratunga K, Hui C, Cameron DW, Mulpuru S, Aaron SD, Momoli F, Zwerling A. International Journal of Circumpolar Health. April 2020.
The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012-2016, Pease C, Zwerling A, Mallick R, Patterson M, Demaio P, Finn S, Allen J, Van Dyk D, Alvarez GG. BMC Infect Dis. 19(1):890. October 2019.
Social determinants of health among residential areas with a high tuberculosis incidence in a remote Inuit community, Kilabuk E, Momoli F, Mallick R, Van Dyk D, Pease C, Zwerling A, Edmunds-Potvin S, Alvarez GG. Journal of Epidemiology & Community Health. Senior author, student first author. January 2019.
A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection, Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Barbeau P, Skidmore B, Alvarez GG. Pharmacoepidemiol Drug Saf. 557-566. Senior author, student first author. June, 2018.
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses, Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Quach P, Skidmore B, Moher D, Alvarez GG. BMC Infectious Diseases 17:265. April, 2017.
Developing and Field Testing a Community Based Youth Initiative to Increase Tuberculosis Awareness in Remote Arctic Inuit Communities. Alvarez GG, Van Dyk DD, Colquhoun H, Moreau KA, Mulpuru S, Graham ID. PLoS One. 2016 Jul 14;11(7):e0159241.
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Alvarez GG, Dyk DDV, Desjardins M, Yasseen AS 3rd, Aaron SD, Cameron DW, Obed N, Baikie M, Pakhale S, Denklnger CM, Sohn H, Pal M. Chest. 2015 Sep;148(3):767-773.
The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community. Alvarez GG, Van Dyk DD, Davies N, Aaron SD, Cameron DW, Desjardins M, Mallick R, Obed N, Baikie M.PLoS One. 2014 Nov 11;9(11):e111986.
Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut. Alvarez GG, VanDyk DD, Aaron SD, Cameron DW, Davies N, Stephen N, Mallick R, Momoli F, Moreau K, Obed N, Baikie M, Osborne G. PLoS One. 2014 Jul 17;9(7):e100975.
A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. Alvarez GG, Sabri E, Ling D, Cameron DW, Maartens G, Wilson D. Int J Tuberc Lung Dis. 2012 Sep;16(9):1247-51.
Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Liu TT, Wilson D, Dawood H, Cameron DW, Alvarez GG. Clin Dev Immunol. 2012;2012:937013.
A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients. Aljohaney A, Amjadi K, Alvarez GG. Clin Dev Immunol. 2012;2012:842045.
A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. Alvarez GG, Gushulak B, Abu Rumman K, Altpeter E, Chemtob D, Douglas P, Erkens C, Helbling P, Hamilton I, Jones J, Matteelli A, Paty MC, Posey DL, Sagebiel D, Slump E, Tegnell A, Valín ER, Winje BA, Ellis E. BMC Infect Dis. 2011 Jan 4;11:3.
Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries. Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, Posey DL, Chemtob D. Int J Tuberc Lung Dis. 2010 Dec;14(12):1530-7.
Tuberculous abscess causing disruption of the cranium. Alvarez GG, Sharma KB, Breen K, Glikstein R, Amand HS, Dasilva V.Can J Neurol Sci. 2010 Nov;37(6):904-5.
Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Schreiber YS, Herrera AF, Wilson D, Wallengren K, Draper R, Muller J, Dawood H, Doucette S, Cameron DW, Alvarez GG. Int J Tuberc Lung Dis. 2009 Oct;13(10):1274-80.
Ocular tuberculosis: diagnostic and treatment challenges. Alvarez GG, Roth VR, Hodge W. Int J Infect Dis. 2009 Jul;13(4):432-5.
“Crack lung and heart" presenting after chemotherapy in a 65-year-old man with non-Hodgkin lymphoma. Alvarez GG, van der Jagt RH. Curr Oncol. 2008 Jan;15(1):63-5
